Significant brain atrophy following new-onset refractory status epilepticus: A rare case of COVID-19 encephalitis
Abstract
The novel coronavirus (SARS-CoV-2) is a highly infectious respiratory virus with significant pathogenicity. Although its impact has lessened in many countries, its ongoing mutations and sporadic outbreaks remain a public health concern. Notably, some cases present severe neurological manifestations. Herein, we report a patient who developed new-onset refractory status epilepticus (NORSE) and significant brain atrophy following SARS-CoV-2 infection.
Fields of Study & Subjects
Long-Term Effects of COVID-19
Infectious Encephalopathies and Encephalitis
Epilepsy research and treatment
Publication details
- Journal / source
- Heliyon
- Volume
- 12
- Issue
- 3
- Pages
- e44603–e44603
- Publication date
- 16 February 2026
- Language
- EN